Response to the letter: "Predictive factors for transition to conversion therapy in HCC using atezolizumab plus bevacizumab".
Tatsuya KikuchiYasuto TakeuchiKazuhiro NousoKazuya KariyamaKenji KuwakiJunichi ToshimoriShota IwadoAkio MoriyaHiroaki HagiharaHiroyuki TakabatakeToshifumi TadaTetsuya YasunakaMasahiro SakataMasahiko SueNozomi MiyakeTakuya AdachiNozomu WadaHideki OnishiHidenori ShirahaAkinobu TakakiMotoyuki OtsukaPublished in: Liver international : official journal of the International Association for the Study of the Liver (2024)
Keyphrases